Cancer Newsline - CA-125 Change Over Time Shows Promise for Early Detection of Ovarian Cancer - MD Anderson Cancer Center

CA-125 Change Over Time Shows Promise for Early Detection of Ovarian Cancer

Cancer Newsline 

Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now show promise as a screening tool for early stage disease. Karen Lu, M.D., and Robert Bast, M.D., discuss their study highlighted at the year's American Society of Clinical Oncology (ASCO) conference.
Guest(s): Karen Lu, M.D., Robert Bast, M.D.

• Listen to CA-125 Change Over Time Shows Promise for Early Detection of Ovarian Cancer
• Download CA-125 Change Over Time Shows Promise for Early Detection of Ovarian Cancer on iTunes U